Bimekizumab Efficacy Through 3 Years in Patients with Moderate to Severe Plaque Psoriasis: Long-term Pooled Analysis from BE BRIGHT. J of Skin. 2024;8(1):s307. doi:10.25251/skin.8.supp.307